Literature DB >> 34674875

Chronic diarrhea and parasitic infections: Diagnostic challenges.

Sumeeta Khurana1, Renu Gur2, Neha Gupta3.   

Abstract

BACKGROUND: Diarrhea is among the top ten global causes of death. Chronic diarrhea may have destructive impact on physical and mental health of patients and is also associated with high risk of mortality in children. Parasitic intestinal infections remain an important cause of chronic diarrhea especially in the developing part of the world.
OBJECTIVE: To study the parasitic causes of chronic diarrhea and highlight the challenges faced in the diagnosis of chronic diarrhea caused due to parasitic infections. CONTENT: Due to non-specific symptoms, insensitive available diagnostic techniques, asymptomatic carriage and transmission, recurrent infections in endemic areas, pose a challenge for diagnosis of the parasitic infections and thus delay the treatment. Conventional techniques like microscopy, though cheaper are not very sensitive. Advanced techniques like molecular methods are more sensitive but expensive and are not readily available in resource limited settings. Newer cost-effective diagnostic techniques with higher sensitivity and specificity are required to detect the infectious agent and for appropriate management.
Copyright © 2021 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic diarrhea; Cryptosporidium; Diagnosis; Parasites

Mesh:

Year:  2021        PMID: 34674875     DOI: 10.1016/j.ijmmb.2021.10.001

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  1 in total

1.  Transition to PCR diagnosis of cryptosporidiosis and giardiasis in the Norwegian healthcare system: could the increase in reported cases be due to higher sensitivity or a change in the testing algorithm?

Authors:  Sophie M Campbell; Frank O Pettersen; Hanne Brekke; Kurt Hanevik; Lucy J Robertson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-03-04       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.